F. Caux

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

P. Joly, Maud Maho‐Vaillant, C. Prost‐Squarcioni et al. · The Lancet · 2017 · 586 citations

Ritux 3, Pharmacology, Pharmacotherapy +2

A Single Cycle of Rituximab for the Treatment of Severe Pemphigus

P. Joly, Hugo Mouquet, Jean‐Claude Roujeau et al. · New England Journal of Medicine · 2007 · 460 citations

Mutations in CGI-58, the Gene Encoding a New Protein of the Esterase/Lipase/Thioesterase Subfamily, in Chanarin-Dorfman Syndrome

Caroline Lefèvre, Florence Jobard, F. Caux et al. · The American Journal of Human Genetics · 2001 · 460 citations · Full text

Mendelian Disorder, Biochemistry, Genetic Disorder +10

High cumulative risks of cancer in patients with <i>PTEN</i> hamartoma tumour syndrome

Virginie Bubien, Françoise Bonnet, Véronique Brouste et al. · Journal of Medical Genetics · 2013 · 358 citations

Diagnosis and management of pemphigus: Recommendations of an international panel of experts

Dédée F. Murrell, S.M. Peña, P. Joly et al. · Journal of the American Academy of Dermatology · 2018 · 356 citations · Full text

Medicine, Dermatology, Pathology +1